Releaf
UK medical cannabis clinic
From Wikipedia, the free encyclopedia
Releaf is a London-based medical cannabis clinic,[1] licensed to prescribe and dispense cannabis-based prescription medicines (CBPMs) in the United Kingdom.[2][3]
 | |
| Industry | Medical cannabis |
|---|---|
| Founded | 2022 |
| Headquarters | London, England |
| Website | releaf |
History
After UK legalisation of medical cannabis in November 2018,[4] Releaf Dispensary Ltd, founded by Mason Soiza,[5] was incorporated on 10 May 2022.[6] Buoyed by a £1.5m funding round in 2023,[1] Releaf developed a health technology platform to ease access to cannabis-based prescription medicines (CBPMs) for patients.[5][7]
Releaf has conducted surveys[7] and organised campaigns to inform medical professionals[8] and to promote broader awareness among potential patients about the CBPMs space including through celebrity users,[9][10] promotion of CBPM ID cards,[2][3] and information about how CBPMs might be consumed.[11]
Releaf is a member of the UK's Cannabis Industry Council.[12]
Chloe Durrington was the first patient in the UK to be prescribed by Releaf with cannabis flower,[13] which was grown legally for commercial sale by Glass Pharms.[14]
In September 2025, Releaf was shortlisted in four categories at the Growing Business Awards 2025[15] and was awarded Young Company Of The Year.[16] The company also acquired the domain name Releaf.com for £110,000 in the same month.[17][18] In October 2025, the company expanded into the German medical cannabis market.[19][20]
In January 2026, Releaf launched a 24/7 legal helpline to provide guidance for UK patients with medical cannabis prescriptions.[21]
Financials
Releaf reported issued share capital of £37,323.83 as of 28 Oct 2025.[22] The company’s most recent accounts reported total assets of £5.61 million with 49 employees.[23]
